A carregar...
Protease mutations emerging on darunavir in protease inhibitor-naïve and experienced patients in the UK
INTRODUCTION: Darunavir (DRV) is a preferred agent in treatment guidelines for ART-naïve and experienced patients [1]. It is considered to have a high genetic barrier to resistance and 11 resistance-associated mutations (RAMs) are recognized by IAS-USA [2]. These have largely been identified by anal...
Na minha lista:
| Publicado no: | J Int AIDS Soc |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
International AIDS Society
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4225433/ https://ncbi.nlm.nih.gov/pubmed/25397484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.17.4.19739 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|